Passage Bio, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| LYNX1 CAPITAL MANAGEMENT LP | 11/13/2025 | 623.70 K | $5.01 M | 100.00% | 19.68% |
| VESTAL POINT CAPITAL, LP | 11/14/2025 | 305.00 K | $2.45 M | 100.00% | 9.62% |
| ERSTE ASSET MANAGEMENT GMBH | 11/12/2025 | 122.79 K | $999.46 K | 100.00% | 3.87% |
| VANGUARD GROUP INC | 11/07/2025 | 117.03 K | $937.41 K | 100.00% | 3.69% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 100.79 K | $809.34 K | 100.00% | 3.18% |
| NEW LEAF VENTURE PARTNERS, L.L.C. | 11/14/2025 | 87.43 K | $702.03 K | -96.50% | 2.76% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2025 | 75.00 K | $602.25 K | 100.00% | 2.37% |
| ORBIMED ADVISORS LLC | 11/14/2025 | 59.05 K | $474.14 K | 100.00% | 1.86% |
| BLACKROCK, INC. | 11/12/2025 | 29.75 K | $238.88 K | 100.00% | 0.94% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 27.28 K | $218.58 K | 100.00% | 0.86% |
| ACADIAN ASSET MANAGEMENT LLC | 11/13/2025 | 25.57 K | $204.00 K | 100.00% | 0.81% |
| SQUAREPOINT OPS LLC | 11/14/2025 | 23.50 K | $188.24 K | 100.00% | 0.74% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2025 | 20.80 K | $166.63 K | 100.00% | 0.66% |
| CITADEL ADVISORS LLC | 11/14/2025 | 19.09 K | $152.92 K | 100.00% | 0.60% |
| FIDUCIARY TRUST CO | 11/14/2025 | 10.75 K | $86.32 K | 100.00% | 0.34% |
| MORGAN STANLEY | 11/14/2025 | 338 | $2.71 K | 100.00% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 289 | $2.32 K | 100.00% | 0.01% |
| BARCLAYS PLC | 11/12/2025 | 212 | $1.70 K | 100.00% | 0.01% |
| MAI CAPITAL MANAGEMENT | 11/10/2025 | 200 | $1.61 K | 100.00% | 0.01% |
| SBI SECURITIES CO., LTD. | 11/05/2025 | 142 | $1.14 K | -95.10% | 0.00% |
| CITIGROUP INC | 11/10/2025 | 77 | $617 | 100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 28 | $225 | 100.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 11/14/2025 | 20 | $141 | 100.00% | 0.00% |
| UBS GROUP AG | 11/13/2025 | 17 | $137 | 100.00% | 0.00% |
| PARALLEL ADVISORS, LLC | 11/13/2025 | 16 | $128 | 100.00% | 0.00% |
| JPMORGAN CHASE & CO | 11/26/2025 | 15 | $120 | 100.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 12 | $96 | 100.00% | 0.00% |
| LRI INVESTMENTS, LLC | 11/03/2025 | 12 | $96 | -94.67% | 0.00% |
| HARBOUR INVESTMENTS, INC. | 11/12/2025 | 3 | $24 | 100.00% | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 11/14/2025 | 2 | $16 | 100.00% | 0.00% |
| JPMORGAN CHASE & CO | 11/26/2025 | 0 | $0 | -100.00% | 0.00% |
| FIDUCIARY TRUST CO | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| NORTHERN TRUST CORP | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| STATE STREET CORP | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| VANGUARD GROUP INC | 11/07/2025 | 0 | $0 | -100.00% | 0.00% |
| BARCLAYS PLC | 11/12/2025 | 0 | $0 | -100.00% | 0.00% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| MORGAN STANLEY | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 11/13/2025 | 0 | $0 | -100.00% | 0.00% |
| GROUP ONE TRADING, L.P. | 11/12/2025 | 0 | $0 | -100.00% | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 0 | $0 | -100.00% | 0.00% |
| ORBIMED ADVISORS LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| RBF CAPITAL, LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 0 | $0 | -100.00% | 0.00% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Passage Bio, Inc. institutional Ownership - FAQ's
During the previous two years, 55 institutional investors and hedge funds held shares of Passage Bio, Inc.. The most heavily invested institutionals were:
Lynx1 Capital Management LP: 623,704
Vestal Point Capital, LP: 305,000
Erste Asset Management GmbH: 122,790
VANGUARD GROUP INC: 117,030
RENAISSANCE TECHNOLOGIES LLC: 100,789
New Leaf Venture Partners, L.L.C.: 87,426
52.03% of Passage Bio, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 4.19 M shares in the last 24 months. This purchase volume represents approximately $33.61 M in transactions.